Actively Recruiting
Cancer Pain Management Using a Web-based Intervention
Led by University of Texas at Austin · Updated on 2025-09-15
300
Participants Needed
1
Research Sites
184 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is funded by the HEAL Initiative (https://heal.nih.gov/). Based on Preliminary Studies (PSs), the research team developed and pilot-tested an evidence-based Web App-based information and coaching/support program for cancer pain management (CAPA) that was culturally tailored to Asian American breast cancer survivors using multiple unique features. However, CAPA rarely considered depressive symptoms accompanying pain in its design or components, and PSs indicated the necessity of further individualization of the intervention components of CAPA due to diversities in the needs of ABD. The purpose of the proposed 2-phase study is to further develop CAPA with additional components for ABD and the individual optimization functionality (CAI) and to test the efficacy of CAI in improving cancer pain experience of ABD. The specific aims are to: a) develop and evaluate CAI through an expert review and a usability test (R61 phase); b) determine whether the intervention group (that uses CAI and usual care) will show significantly greater improvements than the active control group (that uses CAPA and usual care) in primary outcomes (cancer pain management and cancer pain experience including depressive symptoms) from baseline to post 1-month and post 3-months; c) identify theory-based variables (attitudes, self-efficacy, perceived barriers, and social influences) that mediate the intervention effects of CAI on the primary outcomes; and d) determine whether the effects of CAI on the primary outcomes are moderated by selected background, disease, genetic, and situational factors. This study is guided by the Bandura's Theory and the stress and coping framework by Lazarus and Folkman. The R61 phase includes: (a) the intervention development process, (b) a usability test among 15 ABD, 15 family members, and 15 community gatekeepers; and (c) an expert review among 10 experts in oncology. The R33 phase adopts a randomized repeated measures control group design among 300 ABD. Long-term goals are: (a) to extend and test CAI in various healthcare settings with diverse subgroups of ABD, (b) examine the costeffectiveness, sustainability, and scalability of CAI in the settings, and (c) translate CAI into health care for ABD.
CONDITIONS
Official Title
Cancer Pain Management Using a Web-based Intervention
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 18 years and older who identify as Chinese, Korean, or Japanese
- Have had a breast cancer diagnosis in the past
- Can read and write English, Mandarin (simplified or traditional), Korean, or Japanese
- Have access to the internet through computers or mobile devices
- Experienced cancer pain during the past week (at least mild pain on a 0 to 5 scale)
- Experienced depressive symptoms during the past two weeks (minimal to moderate depression on the Patient Health Questionnaire)
You will not qualify if you...
- Younger than 18 years old
- Diagnosed with breast cancer within the past five years, whether currently in treatment or not
- Participated in the principal investigator's pilot studies
- Receiving active depression treatment during the R33 phase
- No internet access (though access through community or group computers is allowed)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The University of Texas at Austin
Austin, Texas, United States, 78712
Actively Recruiting
Research Team
W
Wonshik Chee
CONTACT
O
OVPR
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here